25th Feb 2026 Plain language summary of pegcetacoplan therapy in kidney transplant patients with C3G or primary IC-MPGN from the NOBLE study
25th Feb 2026 Plain language summary of sparsentan clinical trial findings in patients with focal segmental glomerulosclerosis
25th Feb 2026 Long-term outcomes of atacicept therapy in IgA nephropathy patients: a plain language summary
28th Aug 2025 DISCOVERY study findings on pegcetacoplan for treating rare kidney diseases linked to complement system dysfunction: plain language summary
11th Feb 2025 A plain language summary of a study on long-term outcomes in IgA nephropathy patients from the UK Rare Kidney Diseases Registry (RaDaR)
